Evotec AG (NASDAQ:EVTCY)

PRESS RELEASE

published on 08/14/2024 at 07:00, 1 year 10 months ago

Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
Evotec SE reports challenging H1 2024 results with priority reset for sustainable growth. New CEO accelerates transformation program focusing on core strengths

Evotec SE Sustainable Growth Transformation Program CEO Change H1 2024 Results
BRIEF

published on 08/13/2024 at 07:35, 1 year 10 months ago

Evotec Reports Significant Progress in Collaboration with Bristol Myers Squibb

Oncology Evotec Bristol Myers Squibb Molecular Glue Degraders CELMoDs
BRIEF

published on 08/13/2024 at 07:35, 1 year 10 months ago

Evotec annonce des progrès significatifs dans sa collaboration avec Bristol Myers Squibb

Oncologie Evotec Bristol Myers Squibb CELMoDs Dégradeurs De Colle Moléculaire
PRESS RELEASE

published on 08/13/2024 at 07:30, 1 year 10 months ago

Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Evotec SE announces strong progress in strategic partnership with Bristol Myers Squibb for molecular glue degraders, triggering payments of US$75m. Joint pipeline expanding in oncology field

Partnership Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders
BRIEF

published on 08/08/2024 at 07:35, 1 year 10 months ago

Evotec Advances Neuroscience Partnership with Bristol Myers Squibb

Partnership Research Neuroscience Evotec Bristol Myers Squibb
BRIEF

published on 08/08/2024 at 07:35, 1 year 10 months ago

Evotec fait progresser son partenariat en neurosciences avec Bristol Myers Squibb

Partenariat Recherche Evotec Neurosciences Bristol Myers Squibb
PRESS RELEASE

published on 08/08/2024 at 07:30, 1 year 10 months ago

Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
Evotec SE announces progress in strategic neuroscience partnership with Bristol Myers Squibb, receiving US$ 25 million payment for further research on neurodegenerative diseases

Evotec SE Research Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Partnership
BRIEF

published on 08/07/2024 at 13:05, 1 year 10 months ago

Evotec SE to Announce First Half-Year 2024 Results on 14 August 2024

Financial Results Conference Call Evotec SE Webcast First Half-year 2024
BRIEF

published on 08/07/2024 at 13:05, 1 year 10 months ago

Evotec SE annoncera ses résultats du premier semestre 2024 le 14 août 2024

Résultats Financiers Evotec SE Webdiffusion Conférence Téléphonique Premier Semestre 2024
PRESS RELEASE

published on 08/07/2024 at 13:00, 1 year 10 months ago

Evotec SE reports first half-year 2024 results on 14 August 2024
Evotec SE to report first half-year 2024 results on 14 August 2024. Conference call scheduled to discuss financial performance and updates. Webcast available on www.evotec.com/en/investor-relations/financial-publications

Conference Call Financial Performance Evotec SE Webcast First Half-year Results

Published on 06/27/2026 at 16:50, 5 hours 23 minutes ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 20 hours 33 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 22 hours 13 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 23 hours 13 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 23 hours 23 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 22 hours 7 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 22 hours 8 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 22 hours 37 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 22 hours 37 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 22 hours 45 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 1 day 4 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 1 day 4 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 1 day 4 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 1 day 7 hours ago

Safran information
Published on 06/26/2026 at 14:44, 1 day 7 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News